Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins
about
Does accumulation of advanced glycation end products contribute to the aging phenotype?Advanced glycation end products play adverse proinflammatory activities in osteoporosisThe 1.5 A Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand BindingAdvanced glycation end products and diabetic complicationsDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceThe receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking siteA multicellular signal transduction network of AGE/RAGE signalingTIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand bindingThe sour side of neurodegenerative disorders: the effects of protein glycation.FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation.Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.Genetic modifiers of atherosclerosis in miceHigh-mobility group protein box-1 and its relevance to cerebral ischemiaNeurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidineThe multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.The AGE-receptor in the pathogenesis of diabetic complications.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Neurovascular disease, antioxidants and glycation in diabetes.Central role of RAGE-dependent neointimal expansion in arterial restenosis.A comparative profile of methanol extracts of Allium cepa and Allium sativum in diabetic neuropathy in miceDiabetes and periodontitis.Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.Pathogenesis of malaria and clinically similar conditions.Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal TransductionRelationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal WomenGlycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisThe HMGB1 receptor RAGE mediates ischemic brain damage.Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.Role of advanced glycation end products and their receptors in development of diabetic neuropathy.Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-κBCorrelations between Photodegradation of Bisretinoid Constituents of Retina and Dicarbonyl Adduct DepositionCellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium.Arterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetesImaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injuryPeriodontal disease: associations with diabetes, glycemic control and complications.Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly personsAging is not a disease: distinguishing age-related macular degeneration from aging.Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
P2860
Q24632710-CEC84983-6E74-4E9C-ACB6-B44D46F8947BQ27024641-3C21AD8F-8EDB-4B65-95A3-C465A109286DQ27664995-496DC320-7532-497F-A583-251DA353780FQ27687501-42DD5239-EE11-4A9A-903F-5BE704FDB11EQ28344139-D47B231B-70B1-4FBA-92AB-D530EA63D39EQ28645645-6247F87C-15E4-43AE-A142-47588CA2E44FQ28704994-08D833C4-720F-4B09-A2E5-E36F5662B7DAQ28741936-66F744D8-32F0-48EF-B83F-209700D6CFAFQ30386079-0D18ED8C-F9DE-431A-8E31-90FA9D209D5EQ30873486-BCDDE8C7-AD50-410D-9F4C-C4DDE31A5B0AQ33586749-0883FF86-A4FE-4EEF-B9D5-B7B0A426DE03Q33817334-DE6CBD6C-FDED-4A13-B1E0-6004A3EDF568Q34066200-AC40046D-B5E8-44B3-BFCB-E96C5B8FD49FQ34080318-30C7BB2A-93B6-47E3-B811-111885CDF703Q34170847-477A6EF4-4347-4E08-9F51-E5EAC66A23F0Q34374197-C58A0B79-4234-43ED-9E93-1F47D151492AQ34387881-C2EC1344-E1C2-43E6-B12C-BE2B0BA246A2Q34470639-7DF63258-49AF-4223-93A4-3C88A37A7493Q34490546-61E2E888-92BE-4C16-B528-45C1FEA71465Q34804227-3163BCB6-90C6-4139-9700-2ECA0428A9E2Q34890522-C1B689EA-A911-428E-8955-750A28FFE82FQ35036226-11B5D2DE-F771-446C-B2C3-0D7AA0C42285Q35053820-E8571BC5-7CC5-4A57-8C9B-919A7C2ABBE7Q35809946-7B572E6A-154C-42F9-956F-C9625435F3CCQ35838590-CA14F841-9AEB-4003-B9A0-7ED3269BFD57Q35943768-7C3789F9-58CB-4070-8347-6398D23E7FBCQ36047141-48D6F51F-0BA4-43E7-BAC8-2D8ECA714C43Q36052417-6614D486-C840-45D3-A6FB-F9020A7F603BQ36134557-63DD70E4-2463-40CA-B370-FC27FF42135EQ36179583-39107E63-DF99-4C93-B7E1-236118E366D7Q36203976-ED9894DC-652A-479F-9D2D-2E425D34EF2DQ36256454-4F38F188-4AFB-44ED-B6F8-EAE82A5E2731Q36283819-82DDA717-5C05-4FD9-8494-943DE644895CQ36687957-90787056-C57E-48E4-B111-2740046534C0Q36714114-5FF23294-5BA6-46DA-A1D3-035B0A6DF40CQ36795745-6BB21C0E-8EE5-4205-80B2-4F22038A80E8Q37108641-8A75EF3C-EC39-4577-80A6-01E8F658BEB5Q37214116-331DF329-E1EA-4C10-87EA-E62B6FF56EC2Q37315838-C9A0E8D2-FAFB-490A-95FC-F2EDF972741EQ37364608-F3537EE1-0613-4B02-B72E-A4E0EEF83526
P2860
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Receptor for advanced glycatio ...... se to circulating AGE proteins
@ast
Receptor for advanced glycatio ...... se to circulating AGE proteins
@en
type
label
Receptor for advanced glycatio ...... se to circulating AGE proteins
@ast
Receptor for advanced glycatio ...... se to circulating AGE proteins
@en
prefLabel
Receptor for advanced glycatio ...... se to circulating AGE proteins
@ast
Receptor for advanced glycatio ...... se to circulating AGE proteins
@en
P2093
P2860
P356
P1476
Receptor for advanced glycatio ...... se to circulating AGE proteins
@en
P2093
A M Schmidt
G Costache
K Kuwabara
P2860
P304
P356
10.1073/PNAS.91.19.8807
P407
P577
1994-09-01T00:00:00Z